When scheduling an appointment on CVS.com, patients will be asked ... be able to schedule an appointment for a Moderna or Pfizer-BioNTech booster dose if they have had two previous doses with ...

Pfizer's diverse operations put it in an excellent position to grow in the long run. It doesn't have a top weight loss treatment on the market, but that could change. Its above-average dividend ...

Japan will aim to get boosters to about 31 million healthcare workers and high-risk elderly people within six months from their initial inoculation instead of eight, Kishida said.

Pharmaceutical giant Pfizer has agreed to pay $35 million to settle allegations that it unlawfully hindered the sale of Lipitor, a drug prescribed to lower cholesterol, resulting in buyers paying ...

Activist hedge fund manager Jeff Smith outlined his concerns about drugmaker Pfizer on Tuesday but stopped short of offering a solution — saying that's a job for the board of directors.

Pfizer has told 75 employees in Sanford, North Carolina, that their positions have been eliminated. The layoffs come three months after the company axed 150 positions in Sanford following a high ...

Despite that underperformance over the past 2 months, I believe Pfizer stock still deserves its "Buy" rating. In my opinion, the company is likely to exceed the third-quarter 2024 consensus ...

When a novel coronavirus struck in early 2020, Pfizer’sPFE-1.18%decrease; red down pointing triangle chief executive, Dr. Albert Bourla, saw an opportunity to help save the world. He pushed the ...

Guggenheim has earned $172 million from advising Pfizer on nearly $400 billion in acquisitions since 2011. Pfizer’s stock has dropped over 50% since its pandemic peak, following a series of ...

Both appointments are effective today. As Group President, Shah will be responsible for the operational performance and integrated value creation across CVS Caremark, CVS Pharmacy, and the company ...

Pfizer offers a generous 5.73% dividend yield. The stock is trading at an attractive forward P/E of 9.5x 2026 earnings. The company has multiple potential growth drivers in its pipeline. Pfizer's ...

Activist investor Starboard Value is baring its teeth at Pfizer management, more openly going after CEO Albert Bourla’s job. Starboard has called on Pfizer’s board to “hold management ...